The medicine behind the name

What semaglutide does

Semaglutide is a medicine made to act like GLP-1, a hormone released by the gut after eating. It helps regulate appetite and blood sugar. It is an altered version of that hormone, rather than an exact copy.

That tells you what the ingredient does. It does not tell you which product is being offered, why it is being discussed, or whether it fits your health history. Put those questions on the table before comparing services.

• What health problem do I want help with?
• What would I like a doctor or other licensed health professional, called a clinician, to help me understand?
• Which medicine and form are being discussed?

An ingredient can have different uses

The U.S. record checked September 26, 2026 lists semaglutide (Ozempic, Wegovy and Rybelsus). Ozempic and Wegovy each have an injection and a tablet form.

The form matters when reading an article or asking about a prescription. A brand name alone can leave part of the answer out. Ask for the ingredient, brand and form in plain words, then write them together in your notes.

• The injection called semaglutide (Ozempic) is approved for adults with type 2 diabetes. Its uses include blood sugar control and certain heart and kidney risk reductions.
• Semaglutide (Wegovy) has approval for weight management. Its injection also has specific uses for heart risk and liver disease. FDA gave the liver use conditional approval, called accelerated approval, based on improvements in liver samples. It has not been proved to prevent liver failure. Keeping this approval may depend on a further trial confirming a health benefit.
• Ozempic is not approved for weight loss. A prescriber may legally prescribe it for that use, called using it outside its label. That choice does not give Ozempic FDA approval for weight loss.

These approval descriptions reflect the September 26, 2026 library check. They do not decide an individual treatment plan.

Ask what the word specialist means

Treat “semaglutide specialist” as a reason to ask about the person providing care. A polished page or a familiar phrase can leave the actual name hard to find. Get a name for the assessment and a name for follow-up.

State medical boards publish physician license and public discipline information. The Federation of State Medical Boards keeps state board web addresses in a directory.

• Request the clinician’s full name and professional role.
• Ask which state board holds the relevant record.
• Ask about experience with the health concern you want to discuss.
• Keep the name of the person responsible for follow-up.

A license lookup answers a narrow question about a public record. A clean public record alone does not prove skill.

Keep the product question open

The September 26, 2026 check found no generic semaglutide approved for U.S. sale. The one approval found was tentative: FDA found the application acceptable, but the medicine could not yet be sold. A compounded preparation is a separate category.

In compounding, a pharmacy changes or prepares a drug to meet a stated need. A compounded drug does not go through FDA approval.

• Request the full name of the proposed product.
• Ask why that product is being considered for your stated goal.
• Ask for the pharmacy’s name if the conversation moves to dispensing.

A search session can end with questions still open. A useful first result is a short written list: the health concern, the clinician’s name, and the exact product being discussed. Take that list to the care conversation.